newsfilter
← Latest News
GlobeNewswire·

Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2021

NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. ((TSX.V:BTI, OTCQB:BIOAF) (the "Company" or "Bioasis"), a biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics a